Simmons & Simmons has advised Ascendis Pharma A/S on the German law aspects of its US$108 million Initial Public Offering on NASDAQ.
Ascendis Pharma is a biopharmaceutical company focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs.
Simpson Grierson partner Michael Pollard and senior associate Andrew Matthews have acted for US private equity firm Accel Partners on its NZ$132.9 million private placement investment in Xero.
Accel Partners is a leading Silicon Valley venture capital firm, focussing on early and growth stage investments. Xero intends to use the investment to continue to innovate its products and grow the business globally, specifically in the United States and the United Kingdom.
Goh Kian Hwee, Serene Yeo, Cynthia Goh, Mariana Lesmana and Esther Cher from Rajah & Tann's Capital Markets and M&A Practice Groups acted for Tamaris in its proposed placement for a S$30 million subscription of new shares in the capital of Moya Holdings Asia Limited ("Moya").
Moya is listed on the Singapore stock exchange. It is engaged in the investment and development of total water solutions. Together with its subsidiaries, the group aims to be the partner of choice to cities, private and public entities for their reliable, sustainable and cost effective water supply.
Allens has acted for Newcrest Mining Limited on the company's selldown of its stake in Evolution Mining Limited.
The selldown – known as a block trade – will see Newcrest retain a 14.9 per cent share of Evolution. The $106 million raised by the selldown will be used to repay debt.
The Allens team on the matter was led by Partner Richard Kriedemann.
Mr Kriedemann said block trades have become an increasingly common method to effect sales of substantial stakes without creating market disruption.
Charles Russell Speechlys Corporate team has recently advised CareTech Holdings PLC (CareTech), a leading provider of specialist social care services in the UK, on its conditional £21m placing of new shares on the AIM market of the London Stock Exchange.
CareTech’s anticipated market capitalisation following the placing will be approximately £130m.
The net proceeds of the placing will be used to support organic growth, to fund bolt-on acquisitions and property purchases and to strengthen the company’s balance sheet.
Charles Russell Speechlys’ Advisory team recently acted as the legal adviser to Chelverton Growth Trust plc (the Company) on its latest tender offer, which was announced to shareholders on 11 February 2015.
The tender offer is the latest in a series of tender offers by the Company to achieve its core realisation strategy of returning capital to shareholders.
The Charles Russell Speechlys team advising on this transaction was led by Partner Andrew Collins and included Financial Services Associate James Griffiths.
Nabarro is advising Oriel Securities Limited, a Stifel Company, as sponsor and sole bookrunner on the IPO on the main market by Sequoia Economic Infrastructure Income Fund Limited which has raised £150 million (before expenses) through an oversubscribed placing and offer for subscription.
ShunSin Technology Holdings Limited (stock code: 6451) has successfully listed on the Taiwan Stock Exchange. A team led by Shanghai-based senior partner Huang Xiamin served as PRC law counsel for Grand Fortune Securities Co., Ltd., sponsor for the IPO and listing of ShunSin Technology Holdings Limited. The team worked closely with other intermediaries to guarantee the successful launch on the Exchange.
Jiangsu 3A International Advertising Corporation (“3A Advertising”, stock code: 832048) has successfully listed on the National Equities Exchange and Quotation (“NEEQ”) system. 3A Advertising was advised by Shanghai-based partner Wang Yue, attorneys Deng Wei and Yu Zhichao and paralegal Zheng Jianrui.
Shanghai Beitai Industrial Corporation (“Beitai”, stock code: 831972) has successfully listed on the National Equities Exchange and Quotations (“NEEQ”) system. Beitai was advised by Shanghai-based partner Wang Yue, attorneys Deng Wei and Zheng Jianrui and paralegal Yu Zhichao.